ROIV β€” ROIVANT SCIENCES LTD

Ownership history in AlphaCentric Advisors LLC  Β·  6 quarters on record

This page tracks every 13F SEC filing in which AlphaCentric Advisors LLC reported a position in ROIVANT SCIENCES LTD (ROIV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.97% (2025 Q4)
πŸ“Š Avg. % of fund
0.62%
πŸ“… First filed
2023 Q3
πŸ“… Last filed
2025 Q4
⏱ Quarters held
6

Position Intelligence

AlphaCentric Advisors LLC Γ— ROIV AI Analytics

πŸ“ˆ AlphaCentric Advisors LLC outperformed the S&P 500 by +50.2% annually on this ROIV position. Timing score: 50% (2/4 decisions correct). Average cost basis: $10.93. Maximum drawdown during holding period: –6.1%.

πŸ“ˆ Position Alpha vs SPY
+50.2%
annualised excess return

πŸ”₯ Exceptional β€” beat the S&P 500 by 50.2% per year on this position.
4 quarters analyzed

⏱️ Timing Score
50%

➑️ Neutral timing β€” roughly coin-flip accuracy on add/trim calls.
2 of 4 add/trim decisions correct

πŸ’° Entry Quality
$10.93
+98.5% vs current ($21.70)

Best entry: $10.54 (2024 Q1)  Β·  Worst: $11.54 (2024 Q3)

πŸ›‘οΈ Drawdown Resilience
–6.1%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
67%
buy-side decisions

4 adds Β· 2 trims. Bought during 1 of 1 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
↑ Growing
last 4–5 quarters trend

πŸ“ˆ AlphaCentric Advisors LLC has been actively increasing its ROIV allocation β€” a bullish signal from insiders.
Currently 0.97% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    ROIV price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 6 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 45,076 -54,924 -54.9% 0.97% $978K $21.70
2024 Q3 ADDED 100,000 +12,000 +13.6% 0.86% $1.2M $11.54
2024 Q2 REDUCED 88,000 -2,000 -2.2% 0.68% $930K $10.57
2024 Q1 ADDED 90,000 +35,000 +63.6% 0.57% $949K $10.54
2023 Q4 ADDED 55,000 +20,000 +57.1% 0.41% $618K $11.23
2023 Q3 INITIATED 35,000 β€” β€” 0.23% $409K β€”

🏒 Other funds also holding ROIV

As of 2025 Q4 β€” sorted by position size

QVT Financial LP 3Y 7Y 49.1% Patient Square Capital LP 3Y 37.93% Whitefort Capital Management, LP 3Y 11.76% ADAR1 Capital Management, LLC 5.39% BlackBarn Capital Partners LP 4.4% Two Seas Capital LP 3Y 4.38% PENN DAVIS MCFARLAND INC 3Y 7Y 3.86% STEMPOINT CAPITAL LP 3.6% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 3.56% PERCEPTIVE ADVISORS LLC 3Y 7Y 3.09%
← Back to AlphaCentric Advisors LLC Holdings